Shares of Oxford BioDynamics Plc (LON:OBD – Get Rating) reached a new 52-week low on Friday . The company traded as low as GBX 16 ($0.19) and last traded at GBX 16.69 ($0.20), with a volume of 133766 shares traded. The stock had previously closed at GBX 17.50 ($0.21).
Separately, Shore Capital reiterated a “house stock” rating on shares of Oxford BioDynamics in a research note on Friday, February 25th.
The company has a quick ratio of 2.64, a current ratio of 2.91 and a debt-to-equity ratio of 98.42. The business has a 50 day simple moving average of GBX 19.32 and a two-hundred day simple moving average of GBX 25.81. The firm has a market cap of £16.75 million and a PE ratio of -2.33.
Oxford BioDynamics Company Profile (LON:OBD)
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment.
Read More
- eBay’s Long Term Fundamentals Are Intact If You Can Stomach Short Term Volatility
- Honda’s Stock Continues To Fly Under The Radar
- Vuzix Stock Stays Optimistic
- Palo Alto Networks: Pioneering AI in Cybersecurity
- Dividend Stocks and Your Roth IRA
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.